Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Lancet (London, England)|December 21, 1991
Chirality in antirheumatic drugsW F Kean, C J Lock, H E Howard-LockSeminars in Arthritis and Rheumatism|May 1, 1986
D-penicillamine: chemistry and clinical use in rheumatic diseaseH E Howard-Lock, C J Lock, A Mewa, et al.Arthritis and Rheumatism|August 1, 1982
Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritisW F Kean, C J Lock, H E Howard-Lock, et al.Journal of Pharmaceutical Sciences|February 1, 1991
Action of gold sodium thiomalate on experimental thrombosis in vivoW F Kean, C J Lock, D Somers, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1984
Bio-inorganic effects of D-penicillamine in children and in the elderlyW F Kean, N Bellamy, C J Lock, et al.Metal-Based Drugs|May 14, 2008
Structures of gold(i) and silver(i) thiolate complexes of medicinal interest: a review and recent resultsH E Howard-LockJournal of Pharmaceutical Sciences|April 1, 1989
Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human plateletsW F Kean, C J Lock, J Rischke, et al.Clinical Pharmacology and Therapeutics|May 1, 1984
Antithrombin activity of gold sodium thiomalateW F Kean, Y B Kassam, C J Lock, et al.Journal of Pharmaceutical Sciences|December 1, 1988
Biological action of colorless and yellow solutions of gold sodium thiomalate on thrombin activity and the mixed lymphocyte reactionW F Kean, C J Lock, D Singal, et al.Journal of Pharmaceutical Sciences|February 1, 1993
Site of action for the inhibition by gold sodium thiomalate of rabbit platelet activationK M McKague, C J Lock, F McCrae, et al.Pageof 6